Real-world evidence that a novel diagnostic combining molecular testing with pooled antibiotic susceptibility testing is associated with reduced infection severity and lower cost compared with standard urine culture in patients with complicated or persistently recurrent urinary tract infections

​

Lymphedema-associated comorbidities and treatment gap

​

Health and economic benefits of advanced pneumatic compression devices in patients with phlebolymphedema

​

US budget impact of increased payer adoption of the Flexitouch advanced pneumatic compression device in lymphedema patients with advanced chronic venous insufficiency and multiple infections

​

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis

​

Informal care time and cost in a large clinical trial sample of patients with mild to moderate Alzheimer’s Disease: determinants and level of change observed

​

The high direct medical costs of Prader-Willi syndrome

 

Dependence in Alzheimer's disease and service use costs, quality of life, and caregiver burden: the DADE study

​

Cognition in MCI and Alzheimer’s Disease: baseline data from a longitudinal study of the NTB

​

Association between illness progression measures and total cost in Alzheimer's disease

​

Health-related quality of life during natalizumab maintenance therapy for Crohn’s disease

​

Mapping from disease-specific measures to utility: an analysis of the relationships between the inflammatory bowel disease questionnaire and Crohn’s disease activity index in Crohn’s disease and measures of utility

​

Effect of tegaserod on work and daily activity in irritable bowel syndrome with constipation

​

​